NCT04493333 2024-11-27
Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors
University of Arkansas
Phase 2 Terminated
Clinical Trials
4 trialsNCT00972023 2019-09-17
DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer
Barbara Ann Karmanos Cancer Institute
Phase 1 Terminated
NCT02683148 2019-09-09
DHEA in Synovial Sarcoma Patients
Washington University School of Medicine
Phase 1 Terminated
NCT00516542 2012-07-24
Dehydroepiandrosterone (DHEA) and Letrozole in Treating Patients With Metastatic Breast Cancer
OHSU Knight Cancer Institute
Phase 1 Terminated